Trimodality therapy for locally advanced esophageal squamous cell carcinoma: the role of volume-based PET/CT in patient management and prognostication-Reference-Cited by-同舟云学术

Trimodality therapy for locally advanced esophageal squamous cell carcinoma: the role of volume-based PET/CT in patient management and prognostication

Published:2021-08-08 Issue:2 Volume:49 Page:751-762
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Choi Yeonu,Choi Joon Young,Hong Tae Hee,Choi Yoon-La,Oh Dongryul,Woo Sook Young,Shim Young Mog,Zo Jae Ill,Kim Hong Kwan,Lee Kyung Soo

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-021-05487-w.pdf

Reference49 articles.

1. Jeong DY, Kim MY, Lee KS, et al. Surgically resected T1- and T2-stage esophageal squamous cell carcinoma: T and N staging performance of EUS and PET/CT. Cancer Med. 2018;7(8):3561–70. https://doi.org/10.1002/cam4.1617.

2. Jeong DY, Lee KS, Choi JY, et al. Surgically resected esophageal squamous cell carcinoma: patient survival and clinicopathological prognostic factors. Sci Rep. 2020;10(1):5077. https://doi.org/10.1038/s41598-020-62028-5.

3. Huang YC, Lu HI, Huang SC, et al. FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy. BMC Med Imaging. 2017;17(1):1. https://doi.org/10.1186/s12880-016-0171-7.

4. Chuang HH, Macapinlac HA. The evolving role of PET-CT in the management of esophageal cancer. Q J Nucl Med Mol Imaging. 2009;53(2):201–9.

5. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8(3):226–34. https://doi.org/10.1016/S1470-2045(07)70039-6.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study;British Journal of Cancer;2024-06-27

2. PET/CT deep learning prognosis for treatment decision support in esophageal squamous cell carcinoma;Insights into Imaging;2024-06-24

3. Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysis;British Journal of Surgery;2024-05

4. Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review;Annals of Surgical Oncology;2023-09-30

5. HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma;Molecular Biology Reports;2022-10-19